Cargando…

Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke

BACKGROUND AND PURPOSE: The role of autophagy in response to ischemic stroke has been confusing with reports that both enhancement and inhibition of autophagy decrease infarct size and improve post-stroke outcomes. We sought to clarify this by comparing pharmacologic modulation of autophagy in two c...

Descripción completa

Detalles Bibliográficos
Autores principales: Buckley, Kathleen M, Hess, Daniel L, Sazonova, Irina Y, Periyasamy-Thandavan, Sudharsan, Barrett, John R, Kirks, Russell, Grace, Harrison, Kondrikova, Galina, Johnson, Maribeth H, Hess, David C, Schoenlein, Patricia V, Hoda, Md Nasrul, Hill, William D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079187/
https://www.ncbi.nlm.nih.gov/pubmed/24991402
http://dx.doi.org/10.1186/2040-7378-6-8
_version_ 1782323821503578112
author Buckley, Kathleen M
Hess, Daniel L
Sazonova, Irina Y
Periyasamy-Thandavan, Sudharsan
Barrett, John R
Kirks, Russell
Grace, Harrison
Kondrikova, Galina
Johnson, Maribeth H
Hess, David C
Schoenlein, Patricia V
Hoda, Md Nasrul
Hill, William D
author_facet Buckley, Kathleen M
Hess, Daniel L
Sazonova, Irina Y
Periyasamy-Thandavan, Sudharsan
Barrett, John R
Kirks, Russell
Grace, Harrison
Kondrikova, Galina
Johnson, Maribeth H
Hess, David C
Schoenlein, Patricia V
Hoda, Md Nasrul
Hill, William D
author_sort Buckley, Kathleen M
collection PubMed
description BACKGROUND AND PURPOSE: The role of autophagy in response to ischemic stroke has been confusing with reports that both enhancement and inhibition of autophagy decrease infarct size and improve post-stroke outcomes. We sought to clarify this by comparing pharmacologic modulation of autophagy in two clinically relevant murine models of stroke. METHODS: We used rapamycin to induce autophagy, and chloroquine to block completion of autophagy, by treating mice immediately after stroke and at 24 hours post-stroke in two different models; permanent Middle Cerebral Artery Ligation (MCAL), which does not allow for reperfusion of distal trunk of middle cerebral artery, and Embolic Clot Middle Cerebral Artery Occlusion (eMCAO) which allows for a slow reperfusion similar to that seen in most human stroke patients. Outcome measures at 48 hours post-stroke included infarct size analysis, behavioral assessment using Bederson neurological scoring, and survival. RESULTS: Chloroquine treatment reduced the lesion size by approximately 30% and was significant only in the eMCAO model, where it also improved the neurological score, but did not increase survival. Rapamycin reduced lesion size by 44% and 50% in the MCAL and eMCAO models, respectively. Rapamycin also improved the neurological score to a greater degree than chloroquine and improved survival. CONCLUSIONS: While both inhibition and enhancement of autophagy by pharmacological intervention decreased lesion size and improved neurological scores, the enhancement with rapamycin showed a greater degree of improvement in outcomes as well as in survival. The protective action seen with chloroquine may be in part due to off-target effects on apoptosis separate from blocking lysosomal activity in autophagy. We conclude pharmacologic induction of autophagy is more advantageous than its blockade in physiologically-relevant permanent and slow reperfusion stroke models.
format Online
Article
Text
id pubmed-4079187
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40791872014-07-03 Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke Buckley, Kathleen M Hess, Daniel L Sazonova, Irina Y Periyasamy-Thandavan, Sudharsan Barrett, John R Kirks, Russell Grace, Harrison Kondrikova, Galina Johnson, Maribeth H Hess, David C Schoenlein, Patricia V Hoda, Md Nasrul Hill, William D Exp Transl Stroke Med Research BACKGROUND AND PURPOSE: The role of autophagy in response to ischemic stroke has been confusing with reports that both enhancement and inhibition of autophagy decrease infarct size and improve post-stroke outcomes. We sought to clarify this by comparing pharmacologic modulation of autophagy in two clinically relevant murine models of stroke. METHODS: We used rapamycin to induce autophagy, and chloroquine to block completion of autophagy, by treating mice immediately after stroke and at 24 hours post-stroke in two different models; permanent Middle Cerebral Artery Ligation (MCAL), which does not allow for reperfusion of distal trunk of middle cerebral artery, and Embolic Clot Middle Cerebral Artery Occlusion (eMCAO) which allows for a slow reperfusion similar to that seen in most human stroke patients. Outcome measures at 48 hours post-stroke included infarct size analysis, behavioral assessment using Bederson neurological scoring, and survival. RESULTS: Chloroquine treatment reduced the lesion size by approximately 30% and was significant only in the eMCAO model, where it also improved the neurological score, but did not increase survival. Rapamycin reduced lesion size by 44% and 50% in the MCAL and eMCAO models, respectively. Rapamycin also improved the neurological score to a greater degree than chloroquine and improved survival. CONCLUSIONS: While both inhibition and enhancement of autophagy by pharmacological intervention decreased lesion size and improved neurological scores, the enhancement with rapamycin showed a greater degree of improvement in outcomes as well as in survival. The protective action seen with chloroquine may be in part due to off-target effects on apoptosis separate from blocking lysosomal activity in autophagy. We conclude pharmacologic induction of autophagy is more advantageous than its blockade in physiologically-relevant permanent and slow reperfusion stroke models. BioMed Central 2014-06-21 /pmc/articles/PMC4079187/ /pubmed/24991402 http://dx.doi.org/10.1186/2040-7378-6-8 Text en Copyright © 2014 Buckley et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Research
Buckley, Kathleen M
Hess, Daniel L
Sazonova, Irina Y
Periyasamy-Thandavan, Sudharsan
Barrett, John R
Kirks, Russell
Grace, Harrison
Kondrikova, Galina
Johnson, Maribeth H
Hess, David C
Schoenlein, Patricia V
Hoda, Md Nasrul
Hill, William D
Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke
title Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke
title_full Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke
title_fullStr Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke
title_full_unstemmed Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke
title_short Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke
title_sort rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent mcal, and embolic mcao, murine models of stroke
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079187/
https://www.ncbi.nlm.nih.gov/pubmed/24991402
http://dx.doi.org/10.1186/2040-7378-6-8
work_keys_str_mv AT buckleykathleenm rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke
AT hessdaniell rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke
AT sazonovairinay rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke
AT periyasamythandavansudharsan rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke
AT barrettjohnr rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke
AT kirksrussell rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke
AT graceharrison rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke
AT kondrikovagalina rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke
AT johnsonmaribethh rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke
AT hessdavidc rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke
AT schoenleinpatriciav rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke
AT hodamdnasrul rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke
AT hillwilliamd rapamycinupregulationofautophagyreducesinfarctsizeandimprovesoutcomesinbothpermanentmcalandembolicmcaomurinemodelsofstroke